Biozidprodukteg Gebührentarifv 2014 - Bp Gebtv 2014

Original Language Title: BiozidprodukteG-GebührentarifV 2014 – BP-GebTV 2014

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.

291. Regulation of the Federal Minister for Agriculture, Forestry, Environment and Water Management on charges pursuant to Regulation (EU) No 528/2012 on the making available on the market and the use of biocidal products (Biocides-Product-Fee-Tariff 2014-BP-GebTV 2014)

On the basis of § § 4, 5, 7, 11 and 25 of the Federal Act on the Implementation of the Biocidal Products Ordinance, BGBl. I No 105/2013, ('Biocidal Products ') shall be classified as follows:

§ 1. (1) The fees for

1.

a request for the approval or extension of the approval of an active substance in accordance with Articles 7 to 16 of Regulation (EU) No 528/2012 on the making available on the market and use of biocidal products, OJ L 206, 22.7.2012, p. No. OJ L 167 of 27. 06. 1, (hereinafter referred to as the Biocidal Products Regulation) and a request for inclusion of an active substance in the list in Annex I, in accordance with Article 28 of the Biocidal Products Regulation,

2.

a notification of a biocidal product within an authorised biocidal product family in accordance with Article 17 (6) of the Biocidal Products Regulation,

3.

an application for the authorisation of a biocidal product or a biocidal product family in accordance with Articles 17 and 29 of the Biocidal Products Regulation;

4.

an application for the authorisation of a biocidal product or a biocidal product family under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation;

5.

notification of the provision on the market of a biocidal product authorised under the simplified procedure, in accordance with Article 27 of the Biocidal Products Regulation;

6.

an application for the authorisation of a biocidal product or a biocidal product family by mutual recognition in accordance with Articles 33 or 34 of the Biocidal Products Regulation;

7.

an application for the authorisation of a biocidal product or a biocidal product family within the framework of the Union authorisation in accordance with Articles 41 to 44 of the Biocidal Products Regulation;

8.

a request for the approval of a biocidal product or a biocidal product family for parallel trade in accordance with Article 53 of the Biocidal Products Regulation;

9.

an application for the authorisation of a biocidal product or a biocidal product family in the event of a risk of default in accordance with Article 55 (1) of the Biocidal Products Regulation,

10.

a request for the provisional authorisation of a biocidal product or a biocidal product family in accordance with Article 55 (2) of the Biocidal Products Regulation;

11.

a notification of an experiment or trial for research and development purposes in accordance with Article 56 of the Biocidal Products Regulation;

12.

a request for amendment of authorisations or authorisations pursuant to Z 3, 4, 6, 7, 8, 9 and 10,

13.

an application for renewal of authorisations or authorisations pursuant to Z 3, 4, 5, 6, 7, 8, 9 and 10, and

14.

an authorised biocidal product or a biocidal product family, with the exception of a biocidal product authorised in accordance with Z 7 in the framework of a Union authorisation or a biocidal product family, per year

shall be fixed in the facility.

(2) The entire fee for an application, notification or information referred to in paragraph 1 shall include, where appropriate, a validation fee (VG), in accordance with the applicable tariff heading of the installation, which shall be used to verify the formal completeness of the Information and documents within the framework of the procedure, and an evaluation fee (BG) for the evaluation of the particulars and documents with regard to the performance of the material requirements for the execution of the application.

(3) For the purposes of applying the appropriate tariff headings in Sections I to IX of the Annex, which determine the level of the charges in question, the type of application, the biocidal product or the relevant family of biocidal products to which they are based shall be: the application relates to the necessary and used official activities for the treatment of the application and the extent of the documents to be examined.

(4) The fees in accordance with the Appendix shall be paid not later than 30 days after notification by the Authority. If a validation fee is provided for, only the validation fee has to be paid. The evaluation fee shall be paid not later than 30 days after notification of the validation by the Authority. For small and medium-sized enterprises (SMEs) according to Art. 3 (1) lit. ae of the biocidal product regulation may be paid in instalments if the valuation fee exceeds the amount of € 50,000.-. The period for the instalments shall not exceed five years. Proof of compliance with the criteria of an SME is to be found in the application.

The Authority may, where the assessment of an active substance in the cases in Section I, footnote 1, 2 or 3 of the Appendix is associated with significantly less administrative burdens, set a lower valuation fee in individual cases.

(6) Any subsequent withdrawal, rejection or dismissal of the application shall, as a rule, have no effect on the fee level. The Authority may, in such cases, set a lower valuation fee if the applicant does not submit the requested data within the prescribed period, the requested authorisation or authorisation cannot be granted and the administrative burden is as a result.

(7) Adult of the Authority in the event of a risk of default in accordance with Article 55 (1) of the Biocidal Products Regulation by the evaluation of an active substance in the context of an application for the authorisation of a biocidal product in the cases of paragraph 1 Z 9 Barauslagen, has the following: Applicants according to § 76 of the General Administrative Procedure Act 1991-AVG, BGBl. No. 51/1991, as last amended by the Federal Law BGBl. I No 161/2013, to do so.

(8) Adult of the Authority through the processing of an application in accordance with paragraph 1 Barauslagen, for which no tariff items are provided in the Appendix, the applicant has to come up for this pursuant to § 76 AVG. The provisions of paragraphs 2 to 7 shall apply mutatily.

(9) The annual fees (JG) for authorised biocidal products or biocidal product families referred to in paragraph 1 (14) are to be paid by 31 March of the following year. They shall be due for the first time after the end of the calendar year of their authorisation.

§ 2. Increase of the authority by the transmission or by the examination of samples of a biocidal product in the application procedure in accordance with Art. 53 (4) (lit). In accordance with § 76 of the AVG, the applicant shall apply for these cash outlays in accordance with § 76 of the German Biocidal Products Regulation.

§ 3. If the fees are not paid without further notice, they shall be required to be informed by the Authority.

§ 4. (1) This Regulation shall enter into force with the day following the presentation.

(2) The Biocides-G-fee-tariff I, BGBl. II N ° 251/2002, and the Biocide G Fees, BGBl. II No 331/2003, as amended by the BGBl Regulation. II No 75/2012, shall expire at the end of the day of the manifestation.

(3) For procedures pending at the date of entry into force of this Regulation, in which, in accordance with the transitional provision of Article 91 of the Biocidal Products Regulation, the evaluation must be carried out exclusively in accordance with Directive 98 /8/EC, the following shall apply: Due tariffs shall be paid in accordance with the legislation referred to in paragraph 2.

(4) For other procedures other than those referred to in paragraph 3, pending at the date of entry into force of this Regulation, the fee rates shall apply in accordance with the legislation referred to in paragraph 2 only if the assessment has already begun at that date. has been made.

(5) Biocidal products or biocidal product families authorised at the date of entry into force of this Regulation shall be deemed to have been authorised for the first time in 2014 with regard to the annual fees to be paid as of 2014. Biocidal products authorised within a defined framework shall be considered to be a biocidal product family in respect of the annual fees to be paid.

Group-right

Annex

Section I

1. Fees for applications for the approval and renewal of the approval of an active substance pursuant to Articles 7 to 16 of the Biocidal Products Regulation

Charges-art

Rate post

Procedure/official activity

Fee in Euro

VG

1.1.1

Evaluation of an application for authorisation of an active substance (chemical substance) in accordance with Article 8 of the Biocidal Products Regulation, where applicable plus additional fee according to tariff items 1.1.3, 1.4.5, 8.1.1, 8.1.2, 8.1.3, 8.1.4, 8.1.5, 8.1.6

32 000,-

BG

1.1.2

218 000,- 1) , 2)

BG

1.1.3

Additional fee for the evaluation of any other type of product in the approval of an active substance; in addition to the tariff post 1.1.2

88 000,-

VG

1.1.4

Evaluation of an application for authorisation of an active substance (micro-organism) in accordance with Article 8 of the Biocidal Products Regulation, where applicable plus additional fee according to tariff items 1.1.6, 1.4.5, 8.1.1, 8.1.2, 8.1.3, 8.1.4, 8.1.5, 8.1.6

20 000,-

BG

1.1.5

140 000,- 3)

BG

1.1.6

Additional fee for the evaluation of any other type of product in the approval of an active substance; in addition to the tariff post 1.1.5

56 000,-

VG

1.2.1

Evaluation of an application for the renewal of the authorisation of an active substance (chemical substance) in accordance with Article 14 of the Biocidal Products Regulation, which has not yet been evaluated by Austria as a reference Member State, and which has a comprehensive assessment is required, if necessary plus additional fee according to tariff items 1.2.3, 1.4.5

26 000,-

BG

1.2.2

182 000,- 1) , 2)

BG

1.2.3

Additional fee for the evaluation of any other product type in the extension of the approval of an active substance; in addition to the tariff post 1.2.2

70 000,-

VG

1.2.4

Evaluation of an application for the renewal of the authorisation of an active substance (chemical substance) in accordance with Article 14 of the Biocidal Products Regulation, which has already been evaluated by Austria as a reference Member State and which requires a comprehensive assessment is, if necessary Plus additional fee according to tariff item 1.2.6, 1.4.5

24 000,-

BG

1.2.5

164 000,- 1) , 2)

BG

1.2.6

Additional fee for the evaluation of any other product type in the extension of the approval of an active substance; in addition to the tariff post 1.2.5

65 000,-

VG

1.2.7

Evaluation of an application for the renewal of the authorisation of an active substance (micro-organism) in accordance with Article 14 of the Biocidal Products Regulation, which has not yet been evaluated by Austria as a reference Member State and which has a comprehensive assessment is required, if necessary Plus additional fee according to tariff items 1.2.9, 1.4.5

16 000,-

BG

1.2.8

116 000,- 3)

BG

1.2.9

Additional fee for the evaluation of each other product type in the extension of the approval of an active substance; in addition to the tariff post 1.2.8

46 000,-

VG

1.2.10

Evaluation of an application for the renewal of the approval of an active substance (micro-organism) in accordance with Article 14 of the Biocidal Products Regulation, which has already been evaluated by Austria as a reference Member State and which requires a comprehensive assessment is, if necessary Plus additional fee according to tariff item 1.2.12, 1.4.5

15 000,-

BG

1.2.11

100 000,- 3)

BG

1.2.12

Additional fee for the evaluation of each other product type in the extension of the approval of an active substance; in addition to the tariff post 1.2.11

40 000,-

VG

1.3.1

Evaluation of an application for the renewal of the authorisation of an active substance (chemical substance) in accordance with Article 14 of the Biocidal Products Regulation, which has not yet been evaluated by Austria as a reference Member State, and which does not have a comprehensive assessment is required, if necessary Plus additional fee according to Tarifpost 1.3.3

15 600,-

BG

1.3.2

109 400,-

BG

1.3.3

Additional fee for the evaluation of each additional product type in the extension of the approval of an active substance; in addition to the tariff post 1.3.2

25 000,-

VG

1.3.4

Evaluation of an application for the renewal of the authorisation of an active substance (chemical substance) in accordance with Article 14 of the Biocidal Products Regulation, which has already been evaluated by Austria as a reference Member State and which does not have a comprehensive assessment is required, if necessary plus additional fee according to tariff post 1.3.6

12 000,-

BG

1.3.5

82 000,-

BG

1.3.6

Additional fee for the evaluation of any other product type in the extension of the approval of an active substance; in addition to the tariff post 1.3.5

19 000,-

VG

1.3.7

Evaluation of an application for the renewal of the authorisation of an active substance (micro-organism) in accordance with Article 14 of the Biocidal Products Regulation, which has not yet been evaluated by Austria as a reference Member State and which does not have a comprehensive assessment is required, if necessary plus additional fee according to tariff post 1.3.9

9 300,-

BG

1.3.8

65 700,-

BG

1.3.9

Additional fee for the evaluation of each other product type in the extension of the approval of an active substance; in addition to the tariff post 1.3.8

15 000,-

VG

1.3.10

Evaluation of an application for the renewal of the approval of an active substance (micro-organism) in accordance with Article 14 of the Biocidal Products Regulation, which has already been evaluated by Austria as a reference Member State and which does not require a comprehensive assessment is, if necessary plus additional fee according to tariff post 1.3.12

7 000,-

BG

1.3.11

49 000,-

BG

1.3.12

Additional fee for the evaluation of any other product type in the extension of the approval of an active substance; in addition to the tariff post 1.3.11

11 000,-

1)

1.If

a)

the submission of proof of proof referred to in Annex II, Title 1, point 8. or 9. the Biocidal Products Regulation is not required, for scientific reasons, as a whole or on no more than two test proofs from Annex II, Title 1, points 8.1. to 8.4. and 8.7 or point 8.5. and 8.6. or from Annex II, Title 1, point 9.1.2. or 9.1.4. of the Biocidal Products Regulation, or if it is not technically possible to carry out the appropriate tests and the necessary technical final justification for the non-submission by the Authority shall be definitively is accepted, or

b)

a valid access certificate of the person entitled within the meaning of Article 3 (1), entitling the applicant to a valid and transferable proof of proof already available to the Authority, for the said verifications. t of the Biocidal Products Regulation is submitted,

The fees of the tariff post 1.1.2 are reduced to EUR 167 900,-the tariff post 1.2.2 to 140 100,-Euro and the tariff post 1.2.5 to 126 300,-Euro.

2.

If

a)

the submission of proof of proof referred to in Annex II, Title 1, point 8. and 9. the Biocidal Products Regulation is not required for scientific reasons as a whole or is no more than two proof certificates from Annex II, Title 1, points 8.1 to 8.4 and 8.7 or 8.5. and 8.6. and from Annex II, Title 1, point 9.1.2. or 9.1.4. of the Biocidal Products Regulation may be restricted or if it is not technically possible to carry out the appropriate tests and the necessary technical final justification for the non-submission by the Authority is finally accepted, or

b)

a valid access certificate of the person entitled within the meaning of Article 3 (1), entitling the applicant to a valid and transferable proof of proof already available to the Authority, for the said verifications. t of the Biocidal Products Regulation is submitted,

the fees of the tariff post 1.1.2 are reduced to 117 700,-Euro, the tariff post 1.2.2 to 98 200,-Euro and the tariff post 1.2.5 to 90 200,-Euro.

2)

If

1.

, for scientific reasons, at least the submission of proof of proof referred to in Annex II, Title 1, point 8.9.3, 8.9.4, 8.11 and 8.10.3 of the Biocidal Products Regulation is not required or if the carrying out of the appropriate tests is not technically and the necessary technical final justification for the non-submission will be definitively accepted by the Authority, or

2.

at least for the extent of the evidence already available in Z 1 and already available to the Authority, by the applicant a valid access certificate of the person entitled to access valid and transferable proof of proof in the sense of of Art. 3 (1) (lit). t of the Biocidal Products Regulation is submitted,

The fees of the tariff post 1.1.2 are reduced to 200 500,-Euro, the tariff post 1.2.2 to 165 600,-Euro, or the tariff post 1.2.5 to EUR 150 900.-

3) 1.

If, for the whole extent of the audit evidence referred to in Annex II, Title 2, point 7. or for the whole scope of the test documents referred to in Annex II, Title 2, points 8. and 9. the Regulation on Biocidal Products shall provide the applicant with a valid certificate of access of the person entitled within the meaning of Art. 3 (1) (lit) and valid for the reference to the Authority already existing valid and transferable proof of proof. t of the Biocidal Products Regulation is submitted, Tariff post 1.1.5 is reduced to EUR 120 400,-by tariff post 1.2.8 to EUR 99 800,-and by tariff post 1.2.11 to EUR 86 000.-.

2.

If, for the whole extent of the audit evidence referred to in Annex II, Title 2, point 7. and for the full extent of the audit evidence referred to in Annex II, Title 2, points 8. and 9. the Regulation on Biocidal Products shall be submitted by the applicant for such an access certificate, the fees of the tariff post 1.1.5 shall be reduced to 102 200,-Euro, the tariff post 1.2.8 to 84 700,-Euro and the tariff post 1.2.11 to 73 000,-Euro.

Fees for applications for the inclusion of active substances in Annex I to the Biocidal Products Regulation in accordance with Art. 28

Charges-art

Rate post

Procedure/official activity

Fee in Euro

VG

1.4.1

Evaluation of an application for inclusion of an active substance in Annex I, category 1 to 5, in accordance with Article 28 of the Biocidal Products Regulation, which contains data already published and evaluated or generated by the analogue concept

18 000,-

BG

1.4.2

56 000,-

VG

1.4.3

Evaluation of an application for inclusion of an active substance in Annex I, category 6, in accordance with Article 28 of the Biocidal Products Regulation

20 000,-

BG

1.4.4

140 000,-

BG

1.4.5

Additional fee for the verification of compliance with the criteria laid down in Article 28 (2) for the inclusion of an active substance in Annex I, which has already been assessed in respect of the authorisation pursuant to Article 9 of the Biocidal Products Regulation

in addition to tariff items 1.1.2, 1.1.5, 1.2.2, 1.2.5

5 000,-

Section II

Fees for the evaluation of applications under the national authorisation and renewal of the national authorisation of a biocidal product or a biocidal product family in accordance with Articles 17 and 29 and Article 31 and Article 34 (1) of the Biocidal Products Regulation, in the case of Austria acting as the reference Member State

The fees referred to below shall be applicable to a biocidal product or family of biocidal products containing an active substance and to be approved for a product type and category of use. Where applicable, the additional fees referred to in Section VIII shall apply.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

VG

2.1.1

Assessment of an application for national authorisation of a biocidal product in accordance with Art. 29 or Article 34 (1) of the Biocidal Products Regulation, where applicable plus fees according to tariff items 8.2.1, 8.4.1, 8.4.2, 8.6.1, 8.6.2, 8.11.1

5 600,-

BG

2.1.2

39 400,-

VG

2.1.3

Evaluation of an application for national authorisation of a biocidal product family in accordance with Art. 29 or Article 34 (1) of the Biocidal Products Regulation, if applicable plus fees according to tariff items 8.2.2, 8.4.3, 8.4.4, 8.6.3, 8.6.4, 8.11.1

11 300,-

BG

2.1.4

78 700,-

VG

2.2.1

Assessment of an application for national authorisation of a biocidal product in accordance with Article 29 or Article 34 (1) of the Biocidal Products Regulation, which is identical to the reference product evaluated for the active substance authorisation

1,800,-

BG

2.2.2

12 450,-

VG

2.2.3

Assessment of an application for national authorisation of a biocidal product family in accordance with Art. 29 or Article 34 (1) of the Biocidal Products Regulation, which is identical to the reference product evaluated for the active substance authorisation

3 500,-

BG

2.2.4

25 000,-

VG

2.3.1

Evaluation of an application for the renewal of a national authorisation of a biocidal product in accordance with Article 31 of the Biocidal Products Regulation, where a comprehensive assessment is required, where appropriate plus fees according to tariff items 8.3.1, 8.5.1, 8.5.2, 8.6.5

4 600,-

BG

2.3.2

32 400,-

VG

2.3.3

Evaluation of an application for the renewal of a national authorisation of a biocidal product family in accordance with Article 31 of the Biocidal Products Regulation, where a comprehensive assessment is required, if necessary plus fees in accordance with tariff items 8.3.2, 8.5.3, 8.5.4, 8.6.6

9 200,-

BG

2.3.4

64 800,-

VG

2.3.5

Evaluation of an application for the renewal of a national authorisation of a biocidal product in accordance with Article 31 of the Biocidal Products Regulation, where no comprehensive assessment is required, if necessary Plus fees according to heading 8.3.3, 8.5.6

1 500,-

BG

2.3.6

10 400,-

VG

2.3.7

Evaluation of an application for the renewal of a national authorisation of a biocidal product family in accordance with Article 31 of the Biocidal Products Regulation, where a comprehensive assessment is not required, where applicable plus fees according to tariff items 8.3.4, 8.5.8

3 000,-

BG

2.3.8

20 800,-

BG

2.4.1

Evaluation of a notification of a biocidal product belonging to a biocidal product family in accordance with Article 17 (6) of the Biocidal Products Regulation

1 500,-

BG

2.4.2

Evaluation of an application for the authorisation of an identical biocidal product in accordance with Article 17 (7) of the Biocidal Products Regulation in conjunction with Regulation (EU) No 414/2013, provided that the application is subject to an administrative change only in accordance with Annex I Section 1 or Section 2 Regulation (EU) No 354/2013

1 000,-

BG

2.4.3

Assessment of an application for the authorisation of an identical biocidal product in accordance with Article 17 (7) of the Biocidal Products Regulation in conjunction with Regulation (EU) No 414/2013, provided that the application is subject to a number of administrative amendments pursuant to Title I of Annex I to the Regulation 1 and Section 2 Regulation (EU) No 354/2013

1 500,-

BG

2.4.4

Evaluation of an application for authorisation of an identical biocidal product family in accordance with Article 17 (7) of the Biocidal Products Regulation in conjunction with Regulation (EU) No 414/2013, provided that the application is subject to an administrative change only in accordance with Annex Title I, Section 1, or Section 2, Regulation (EU) No 354/2013

2 000,-

BG

2.4.5

Evaluation of an application for the authorisation of an identical biocidal product family in accordance with Article 17 (7) of the Biocidal Products Regulation in conjunction with Regulation (EU) No 414/2013, provided that the application is subject to a number of administrative amendments pursuant to Title I of Annex I to the Regulation Section 1 and Section 2 Regulation (EU) No 354/2013

3 000,-

Section III

Fees for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family under the simplified authorisation procedure laid down in Article 17 (6), (25) and (26) and Article 27 (1) of the Biocidal Product Regulation

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

3.1.1

Evaluation of an application for authorisation of a biocidal product under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation, which contains an active substance from Annex I, Category 1, 2, 3, 4, 5 or 7

10 000,-

BG

3.1.2

Evaluation of an application for authorisation of a biocidal product under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation, which contains an active substance from Annex I, category 6

5 000,-

BG

3.1.3

Evaluation of an application for authorisation of a biocidal product under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation, which is identical to the reference product for inclusion in the active substance in Annex I, Category 6 has been evaluated

2 000,-

BG

3.2.1

Evaluation of an application for authorisation of a biocidal product family under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation, which contains an active substance from Annex I, Category 1, 2, 3, 4, 5 or 7

14 300,-

BG

3.2.2

Evaluation of an application for authorisation of a biocidal product family under the simplified authorisation procedure laid down in Articles 25 and 26 of the Biocidal Products Regulation, which contains an active substance from Annex I, category 6

5 000.

BG

3.3.1

Evaluation of an application for the renewal of an authorisation for a biocidal product under the simplified authorisation procedure

3 000,-

BG

3.3.2

Evaluation of an application for the renewal of an authorisation for a biocidal product family in the context of the simplified authorisation procedure

6 000,-

BG

3.4.1

Evaluation of a notification of a biocidal product belonging to a biocidal product family in accordance with Article 17 (6) of the Biocidal Products Regulation, which has been authorised under the simplified authorisation procedure

300,-

BG

3.4.2

Assessment of the provision of information on the provision on the market of a biocidal product authorised in another Member State in accordance with the simplified authorisation procedure, in accordance with Article 27 (1) of the Biocidal Products Regulation, which consists of an active substance Annex I, Category 1, 2, 3, 4, 5, or 7 contains

2 000,-

BG

3.4.3

Assessment of the provision of information on the provision on the market of a biocidal product authorised in another Member State in accordance with the simplified authorisation procedure, in accordance with Article 27 (1) of the Biocidal Products Regulation, which consists of an active substance Annex I, Category 6, contains

1 000,-

BG

3.4.4

Assessment of information on the provision on the market of a biocidal product family authorised in accordance with the simplified authorisation procedure in another Member State in accordance with Article 27 (1) of the Biocidal Products Regulation, which shall issue an active substance Annex I, Category 1, 2, 3, 4, 5, or 7 contains

3 000,-

BG

3.4.5

Assessment of information on the provision on the market of a biocidal product family authorised in accordance with the simplified authorisation procedure in another Member State in accordance with Article 27 (1) of the Biocidal Products Regulation, which shall issue an active substance Annex I, Category 6, contains

1 500,-

BG

3.4.6

Assessment of information on the provision of a biocidal product on the market which is part of a biocidal product family authorised under the simplified authorisation procedure in another Member State, and in another Member State Member State has already been notified

300,-

Section IV

Fees for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family by mutual recognition pursuant to Art. 17 (6), Articles 33 and 34 (2) of the Biocidal Products Regulation, if Austria concerned Member State is

The fees referred to below shall be applicable to a biocidal product or family of biocidal products containing an active substance and to be approved for a product type and category of use. Where applicable, the additional fees referred to in Section VIII shall apply.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

4.1.1

Evaluation of an application for authorisation of a biocidal product by means of mutual recognition pursuant to Articles 33 and 34 (2) of the Biocidal Products Regulation, where applicable plus fees according to tariff items 8.7.1, 8.8.1, 8.8.2, 8.10.1, 8.10.2

7 700,-

BG

4.1.2

Evaluation of an application for authorisation of a biocidal product family by means of mutual recognition pursuant to Articles 33 and 34 (2) of the Biocidal Products Regulation, if applicable plus fees according to tariff items 8.7.2, 8.8.3, 8.8.4, 8.10.3, 8.10.4

15 400,-

BG

4.2.1

Evaluation of an application for the renewal of an authorisation of a biocidal product by means of mutual recognition in accordance with Articles 33 and 34 (2) of the Biocidal Products Regulation, where a comprehensive assessment is required, where appropriate plus fees according to tariff items 8.7.3, 8.9.1, 8.9.2

6 200,-

BG

4.2.2

Evaluation of an application for the renewal of an authorisation of a biocidal product family by mutual recognition in accordance with Articles 33 and 34 (2) of the Biocidal Products Regulation, where a comprehensive assessment is required, where applicable plus fees according to tariff items 8.7.4, 8.9.3, 8.9.4

12 400,-

BG

4.2.3

Evaluation of an application for the renewal of an authorisation of a biocidal product by mutual recognition in accordance with Articles 33 and 34 (2) of the Biocidal Products Regulation, in which no comprehensive assessment is required, where applicable plus fees according to tariff posts 8.7.5, 8.9.5, 8.9.6

2 100,-

BG

4.2.4

Evaluation of an application for the renewal of an authorisation of a biocidal product family by mutual recognition in accordance with Articles 33 and 34 (2) of the Biocidal Products Regulation, in which no comprehensive assessment is required, where applicable plus fees in accordance with tariff items 8.7.6, 8.9.7, 8.9.8

4 200,-

BG

4.3.1

Evaluation of a notification of a biocidal product belonging to a biocidal product family in accordance with Article 17 (6) of the Biocidal Products Regulation

300,-

Section V

Fees for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family within the framework of the Union authorisation pursuant to Articles 41 to 44 and Article 45 of the Biocidal Products Regulation if Austria is to be considered as an applicant Member State shall carry out evaluation

The fees referred to below shall be applicable to a biocidal product or family of biocidal products containing an active substance and to be approved for a product type and category of use. Where applicable, the additional fees referred to in Section VIII shall apply.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

VG

5.1.1

Evaluation of an application for authorisation of a biocidal product within the framework of the Union authorisation in accordance with Article 43 of the Biocidal Products Regulation, where applicable plus fees according to tariff items 8.2.1, 8.4.1, 8.4.2, 8.5.1, 8.6.1. 8.6.2

7 500,-

BG

5.1.2

52 500,-

VG

5.1.3

Evaluation of an application for authorisation of a biocidal product family within the framework of the Union authorisation in accordance with Article 43 of the Biocidal Products Regulation, where applicable plus fees according to tariff items 8.2.2, 8.4.3, 8.4.4, 8.5.3, 8.6.3, 8.6.4

15 000,-

BG

5.1.4

105 000,-

VG

5.2.1

Evaluation of an application for authorisation of a biocidal product within the framework of the Union authorisation in accordance with Article 43 of the Biocidal Products Regulation, which is identical to the reference product evaluated for the active substance authorisation

2 000,-

BG

5.2.2

16 000,-

VG

5.2.3

Evaluation of an application for authorisation of a biocidal product family within the framework of the Union authorisation in accordance with Article 43 of the Biocidal Products Regulation, which is identical to the reference product which has been evaluated for the authorisation of active substances

4 500,-

BG

5.2.4

31 500,-

VG

5.3.1

Evaluation of an application for an extension of the Union authorisation of a biocidal product in accordance with Article 45 of the Biocidal Products Regulation, where a comprehensive assessment is required, where appropriate plus fees according to tariff items 8.3.1, 8.5.1, 8.5.2, 8.6.5

6 000,-

BG

5.3.2

42 000,-

VG

5.3.3

Evaluation of an application for an extension of the Union authorisation of a biocidal product family in accordance with Article 45 of the Biocidal Products Regulation, where a comprehensive assessment is required, if necessary plus fees in accordance with tariff items 8.3.2, 8.5.3, 8.5.4, 8.6.6

12 000,-

BG

5.3.4

84 000,-

VG

5.3.5

Evaluation of an application for an extension of the Union authorisation of a biocidal product in accordance with Article 45 of the Biocidal Products Regulation, which does not require a comprehensive assessment, if necessary Plus fees according to heading 8.3.3, 8.5.5, 8.5.6

1 900,-

BG

5.3.6

13 100,-

VG

5.3.7

Evaluation of an application for an extension of the Union authorisation of a biocidal product family in accordance with Article 45 of the Biocidal Products Regulation, where a comprehensive assessment is not required, if necessary Plus fees according to tariff items 8.3.4, 8.5.7, 8.5.8

3 800,-

BG

5.3.8

26 200,-

Section VI

Fees for applications for amendment of an authorisation of a biocidal product or a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation when Austria is the reference Member State or Member State applying the assessment

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

6.1.1

Evaluation of an application for modification of the authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in the case of the administrative changes referred to in Title 1, Section 1, point 1. to 4. of Regulation (EU) No 354/2013

500,-

BG

6.1.2

Evaluation of an application for modification of an authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in the case of the administrative amendments referred to in Title 1, Section 1, point 5. and 6. and Section 2 frt Regulation (EU) No 354/2013 is required

800,-

BG

6.1.3

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in respect of which administrative changes are made in accordance with the provisions of Title 1 (1) of Annex I to the Regulation Point 1. to 4. of Regulation (EU) No 354/2013

500,-

BG

6.1.4

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in which the administrative changes referred to in Annex Title 1, Section 1 Point 5. and 6. and Section 2 of Regulation (EU) No 354/2013

1 500,-

VG

6.2.1

Evaluation of an application for modification of an authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 7 of Regulation (EU) No 354/2013, where minor changes are required

500,-

BG

6.2.2

3 000,-

VG

6.2.3

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 7 of Regulation (EU) No 354/2013, where minor changes are required

1 000,-

BG

6.2.4

6 000,-

VG

6.3.1

Evaluation of an application for modification of the authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 8 of Regulation (EU) No 354/2013, which requires substantial changes

2 800,-

BG

6.3.2

19 700,-

BG

6.3.3

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 8 of Regulation (EU) No 354/2013, which requires substantial changes

5 600,-

BG

6.3.4

39 400,-

Section VII

Fees for applications for amendment of an authorisation of a biocidal product or a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation if Austria is concerned Member State

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

7.1.1

Evaluation of an application for modification of an authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in the case of the administrative changes referred to in Annex Title 1, Section 1, point 1. to 4. of Regulation (EU) No 354/2013

400,-

BG

7.1.2

Evaluation of an application for modification of an authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in the case of the administrative changes referred to in Annex Title 1, Section 1, point 5. and 6. and Section 2 of Regulation (EU) No 354/2013

700,-

BG

7.1.3

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in the case of administrative changes in accordance with the Annex, Title 1 Section 1 point 1. to 4. Regulation (EU) No 354/2013 is required

500,-

BG

7.1.4

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation in conjunction with Article 6 of Regulation (EU) No 354/2013, in which the administrative changes referred to in Annex Title 1, Section 1 Point 5. and 6. and Section 2 of Regulation (EU) No 354/2013

1 300,-

BG

7.2.1

Evaluation of an application for modification of an authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 7 of Regulation (EU) No 354/2013, where minor changes are required

500,-

BG

7.2.2

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 7 of Regulation (EU) No 354/2013, where minor changes are required

1 000,-

BG

7.3.1

Evaluation of an application for modification of the authorisation of a biocidal product in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 8 of Regulation (EU) No 354/2013, which requires substantial changes

3 500,-

BG

7.3.2

Evaluation of an application for amendment of an authorisation of a biocidal product family in accordance with Article 50 of the Biocidal Products Regulation, in conjunction with Article 8 of Regulation (EU) No 354/2013, which requires substantial changes

7 000,-

Section VIII

Additional fees

Where applicable, the fees referred to below shall be added to the fees referred to in Sections I, II, IV and V.

1. Fees for applications for provisional authorisation of a biocidal product or a biocidal product family in accordance with Article 55 (2) of the Biocidal Products Regulation

In the case of the biocidal product or biocidal product family applied for, the fees referred to below shall be the reference product, the fee for the evaluation of the active substance (Section I), for which Austria is the Perform an evaluation, add.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.1.1

Evaluation of an application for the provisional authorisation of a biocidal product pursuant to Article 55 (2) of the Biocidal Products Regulation

in addition to tariff post 1.1.2, 1.1.5

5 000,-

BG

8.1.2

Evaluation of an application for provisional authorisation of a biocidal product in accordance with Article 55 (2) of the Biocidal Products Regulation: the further active substance already authorised in the biocidal product

in addition to tariff post 1.1.2, 1.1.5

1 000,-

BG

8.1.3

Evaluation of an application for the provisional authorisation of a biocidal product family in accordance with Article 55 (2) of the Biocidal Products Regulation

in addition to tariff post 1.1.2, 1.1.5

10 000,-

BG

8.1.4

Evaluation of an application for the provisional authorisation of a biocidal product family in accordance with Article 55 (2) of the Biocidal Products Regulation: the further active substance already authorised in the biocidal product

in addition to tariff post 1.1.2, 1.1.5

2 000,-

BG

8.1.5

Evaluation of an application for the provisional authorisation of a biocidal product in accordance with Article 55 (2) of the Biocidal Products Regulation if the biocidal product is identical to the reference product evaluated for the active substance authorisation

in addition to tariff post 1.1.2, 1.1.5

2 000,-

BG

8.1.6

Evaluation of an application for the provisional authorisation of a biocidal product family in accordance with Article 55 (2) of the Biocidal Products Regulation, if the biocidal product is identical to the reference product evaluated for the active substance authorisation

in addition to tariff post 1.1.2, 1.1.5

4 000,-

Additional fees for applications for national authorisation and renewal of national authorisation as well as Union authorisation and renewal of the Union authorisation of a biocidal product or of a biocidal product family, if Austria is the Reference Member State or Member State evaluating the evaluation

2.1 Additional charges for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family in procedures pursuant to Articles 17 and 29, Art. 31 and Article 34 (1) of the Biocidal Products Regulation, if more than one active substance , one or more substances of concern (as referred to in Article 3 (1) (lit)). (f) the Biocidal Products Regulation), more than one product type has been affected and/or more than one user category has been requested.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.2.1

In the context of the evaluation of an application for authorisation of a biocidal product

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.1.2, 5.1.2

5 000,-

BG

8.2.2

In the context of the evaluation of an application for authorisation of a biocidal product family

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.1.4, 5.1.4

10 000,-

BG

8.3.1

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product, which requires a comprehensive assessment

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.3.2, 5.3.2

4 000,-

BG

8.3.2

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product family, where a comprehensive assessment is required

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.3.4, 5.3.4

8 000,-

BG

8.3.3

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product in which a comprehensive assessment is not required

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.3.6, 5.3.6

1 250,-

BG

8.3.4

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product family, where no comprehensive assessment is required

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 2.3.8, 5.3.8

2 500,-

2.2 Additional charges for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family in procedures pursuant to Articles 17 and 29, Art. 31 and Article 34 (1) of the Biocidal Products Regulation, if it is to be replaced Active substances according to Article 10 of the Biocidal Products Regulation shall be included in these biocidal products.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.4.1

In the context of the evaluation of an application for authorisation of a biocidal product

-

Comparative assessment pursuant to Article 23 of the Biocides Product Regulation for an active substance to be replaced

23 800,-

BG

8.4.2

-

and the further active substance to be replaced

in addition to tariff items 2.1.2, 5.1.2

11 900,-

BG

8.4.3

In the context of the evaluation of an application for authorisation of a biocidal product family

-

Comparative assessment pursuant to Article 23 of the Biocides Product Regulation for an active substance to be replaced

45 000,-

BG

8.4.4

-

and the further active substance to be replaced

in addition to tariff items 2.1.4, 5.1.4

22 500,-

BG

8.5.1

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product

-

Comparative assessment pursuant to Article 23 of the Biocides Product Regulation for an active substance to be replaced

19 000,-

BG

8.5.2

-

and the further active substance to be replaced

in addition to tariff items, 2.3.2, 5.3.2

9 500,-

BG

8.5.3

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product family

-

Comparative assessment pursuant to Article 23 of the Biocides Product Regulation for an active substance to be replaced

38 000,-

BG

8.5.4

-

and the further active substance to be replaced

in addition to tariff items 2.3.4, 5.3.4

19 000,-

BG

8.5.5

In the context of the evaluation of an application for the renewal of the authorisation of a biocidal product in which a comprehensive assessment is not required

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

6 200,-

BG

8.5.6

-

and the further active substance to be replaced

in addition to tariff items 2.3.6, 5.3.6

3 100,-

BG

8.5.7

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product family, where no comprehensive assessment is required

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

12 400,-

BG

8.5.8

-

and the further active substance to be replaced

in addition to tariff items 2.3.8, 5.3.8

6 200,-

2.3 Additional charges for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family in procedures pursuant to Articles 17 and 29, Art. 31 and Article 34 (1) of the Biocidal Products Regulation, if the establishment of Maximum residue limits (MRLs) are required.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.6.1

Evaluation of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product, if it does not already apply in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff items 2.1.2, 5.1.2

7 500,-

BG

8.6.2

Assessment of an application for the establishment of maximum residue limits in accordance with Article 19 (7) of the Biocidal Products Regulation for a biocidal product, if it has already been submitted in accordance with the provisions of Article 19 (1) (1) (1) (1) of the Biocidal Product Regulation. (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff items 2.1.2, 5.1.2

1 000,-

BG

8.6.3

Assessment of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product family, if it does not already apply in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product order has been established and is applicable

in addition to tariff items 2.1.4, 5.1.4

12 000,-

BG

8.6.4

Evaluation of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product family, if it has already been submitted in accordance with the provisions of Article 19 (1) (1) (1) (1) (1) of the Biocidal Products Directive (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff items 2.1.4, 5.1.4

1 500,-

BG

8.6.5

Evaluation of an application for the renewal of an authorisation of a biocidal product-new or amended setting of maximum residue limits in accordance with Article 19 (7) of the Biocidal Products Regulation, if it does not already apply in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff items 2.3.2, 5.3.2

5 000,-

BG

8.6.6

Evaluation of an application for the renewal of an authorisation of a biocidal product family-new or amended setting of maximum residue limits in accordance with Article 19 (7) of the Biocidal Products Regulation, if not already in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff items 2.3.4, 5.3.4

10 000,-

Additional fees for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family if Austria is the Member State concerned

3.1 Additional charges for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family in proceedings under Art. 31, Art. 33 and Article 34 (2) of the Biocidal Products Regulation, if more than one active substance , one or more substances of concern (as referred to in Article 3 (1) (lit)). (f) the Biocidal Products Regulation), more than one product type has been affected and/or more than one user category has been requested.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.7.1

In the context of the evaluation of an application for authorisation of a biocidal product

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 4.1.1

650,-

BG

8.7.2

In the context of the evaluation of an application for authorisation of a biocidal product family

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 4.1.2

1 300,-

BG

8.7.3

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product; comprehensive assessment

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to subheading 4.2.1

500,-

BG

8.7.4

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product family; comprehensive assessment

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to subheading 4.2.2

1 000,-

BG

8.7.5

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product; no comprehensive assessment

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to tariff items 4.2.3

200,-

BG

8.7.6

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product family; no comprehensive assessment

-

the further active substance contained in the biocidal product

-

for each additional product type

-

for each additional user category

-

Substance of concern for each substance

in addition to subheading 4.2.4

400,-

3.2 Additional charges for applications for authorisation and renewal of the authorisation of a biocidal product or a biocidal product family in proceedings under Article 31, Article 33 and Article 34 (2) of the Biocidal Products Regulation, if active substances to be replaced have been submitted in accordance with Article 10 of the Biocidal Products Regulation is included in these biocidal products.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.8.1

In the context of the evaluation of an application for authorisation of a biocidal product

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

4 200,-

BG

8.8.2

-

and the further active substance to be replaced

in addition to tariff post 4.1.1

2 100,-

BG

8.8.3

In the context of the evaluation of an application for authorisation of a biocidal product family

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

8 500,-

BG

8.8.4

-

and the further active substance to be replaced

in addition to tariff post 4.1.2

4 200,-

BG

8.9.1

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product in which a comprehensive assessment is required

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for a contained active substance to be replaced

3 300,-

BG

8.9.2

-

and the further active substance to be replaced

in addition to tariff post 4.2.1

1 600,-

BG

8.9.3

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product family, which requires a comprehensive assessment

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

6 600,-

BG

8.9.4

-

and the further active substance to be replaced

in addition to tariff post 4.2.2

3 300,-

BG

8.9.5

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product in which a comprehensive assessment is not required

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

1 100,-

BG

8.9.6

-

and the further active substance to be replaced

in addition to tariff post 4.2.3

500,-

BG

8.9.7

In the context of the evaluation of an application for the renewal of an authorisation of a biocidal product family, where no comprehensive assessment is required

-

Comparative assessment pursuant to Article 23 of the Biocidal Products Regulation for an active substance to be replaced

2 200,-

BG

8.9.8

-

and the further active substance to be replaced

in addition to subheading 4.2.4

1 000,-

3.3 Additional charges for applications for authorisation of a biocidal product or a biocidal product family in procedures pursuant to Art. 31, Art. 33 and Article 34 (2) of the Biocidal Products Regulation, if the establishment of maximum residue limits (MRLs) is required is.

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.10.1

Evaluation of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product, if it does not already apply in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff post 4.1.1

1 200,-

BG

8.10.2

Assessment of an application for the establishment of maximum residue limits in accordance with Article 19 (7) of the Biocidal Products Regulation for a biocidal product, if it has already been submitted in accordance with the provisions of Article 19 (1) (1) (1) (1) of the Biocidal Product Regulation. (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff post 4.1.1

150,-

BG

8.10.3

Assessment of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product family, if it does not already apply in accordance with the provisions of Article 19 (1) (1) (1). (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff post 4.1.2

1 800,-

BG

8.10.4

Evaluation of an application for the establishment of maximum residue limits pursuant to Article 19 (7) of the Biocidal Products Regulation for a biocidal product family, if it has already been submitted in accordance with the provisions of Article 19 (1) (1) (1) (1) (1) of the Biocidal Products Directive (e) the legislation referred to in the biocidal product regulation has been established and is applicable

in addition to tariff post 4.1.2

220,-

4. Other additional fees

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

8.11.1

Evaluation of an application for authorisation of a biocidal product or a biocidal product family by Austria as a reference Member State, if an alternative dossier is submitted for an active substance contained therein, which is not yet available from another Member State has been assessed

in addition to tariff items 2.1.2, 2.1.4

125 000,-

Section IX

Other fees for an application or notification procedure pursuant to Art. 53 (1), Art. 55 (1) subs. 1, Art. 56 (2) and Art. 66 (4) of the Biocidal Products Regulation

Charges-art

Rate post

Procedure/official activity

Fee in Euro

BG

9.1.1

Authorisation for parallel trade for a biocidal product in accordance with Article 53 (1) of the Biocidal Products Regulation

2 000,-

BG

9.1.2

Extension of the authorisation for parallel trade in a biocidal product pursuant to Article 53 (1) of the Biocidal Products Regulation

1 600,-

BG

9.1.3

Evaluation of an application for a derogation pursuant to Article 55 (1), first subparagraph, of the Biocidal Products Regulation

12 000,- 4)

BG

9.1.4

Notification of an experiment or trial pursuant to Art. 56 (2) of the Biocidal Products Regulation

1 000,-

BG

9.1.5

Evaluation of a request for confidential treatment of data pursuant to Art. 66 (4) of the Biocidal Products Regulation, the detailed information not covered by Art. 66 (2)

100,-

Section X

Annual fees

Charges-art

Rate post

Biocidal product/biocidal product family

Fee in Euro

JG

10.1.1

Annual fee for an approved biocidal product per calendar year

500,-

JG

10.1.2

Annual fee for an approved biocidal product family per calendar year

1 000,-

4)

Where an application for authorisation of a biocidal product in the event of a risk of default under the provisions of Article 55 (1) (1) of the Biocidal Products Regulation may be denied only if, in the procedure, an evaluation of the active substance within the meaning of Articles 7 and 8 of the Biocidal Products Regulation is also to be discussed. Biocidal product regulation shall be carried out by the applicant in accordance with § 76 AVG (AVG), the cash outlays resulting from the evaluation of the active substance.